Cited by 34Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesGenomics and Rare DiseasesPrenatal Screening and Diagnostics

Whole-Exome Sequencing for Diagnosis of Turner Syndrome: Toward Next-Generation Sequencing and Newborn Screening

Open access
Murdock, David R., Donovan, Frank X., Chandrasekharappa, Settara C., Banks, Nicole, Bondy, Carolyn, Muenke, Maximilian, Kruszka, Paul·2017·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Turner syndrome (TS) is due to a complete or partial loss of an X chromosome in female patients and is not currently part of newborn screening (NBS). Diagnosis is often delayed, resulting in missed crucial diagnostic and therapeutic opportunities. Objectives: This study sought to determine if whole-exome sequencing (WES) as part of a potential NBS program could be used to diagnose TS. Design, Setting, Patients: Karyotype, chromosomal microarray, and WES were performed on blood samples from women with TS (n = 27) enrolled in the Personalized Genomic Research study at the National Institutes of Health. Female control subjects (n = 37) and male subjects (n = 27) also underwent WES. Copy number variation was evaluated using EXCAVATOR2 and B allele frequency was calculated from informative single nucleotide polymorphisms. Simulated WES data were generated for detection of low-level mosaicism and complex structural chromosome abnormalities. Results: We detected monosomy for chromosome X in all 27 TS samples, including 1 mosaic for 45,X/46,XX and another with previously unreported material on chromosome Y. Sensitivity and specificity were both 100% for the diagnosis of TS with no false-positive or false-negative results. Using simulated WES data, we detected isochromosome Xq and low-level mosaicism as low as 5%. Conclusion: We present an accurate method of diagnosing TS using WES, including cases with low-level mosaicism, isochromosome Xq, and cryptic Y-chromosome material. Given the potential use of next-generation sequencing for NBS in many different diseases and syndromes, we propose WES can be used as a screening test for TS in newborns.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2016-3414

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Whole-exome sequencing has been shown to accurately diagnose TS, including cases with low-level mosaicism, isochromosome Xq, and cryptic Y material.

    “Whole-exome sequencing has also been shown to accurately diagnose TS, including cases with low-level mosaicism, isochromosome Xq, and cryptic Y material.94”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Murdock, D. R., Donovan, F. X., Chandrasekharappa, S. C., Banks, N., Bondy, C., Muenke, M., & Kruszka, P.
Affiliations
National Institutes of Health (US)
Corresponding author
Kruszka, Paul
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-01-24
Volume
102
Issue
5
Pages
1529-1537
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2611282821
Cited by
34
References
40
Citations by year
2026: 2 · 2025: 1 · 2024: 6 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 1
FWCI
2.72
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
Keywords
Turner syndrome, exome sequencing, newborn screening, X chromosome monosomy, 45,X/46,XX mosaicism, isochromosome Xq, copy number variation, B-allele frequency, sensitivity and specificity, simulated sequencing data
MeSH terms
Adult, Aged, Female, Humans, Infant, Newborn, Karyotyping, Male, Middle Aged, Mosaicism, Sensitivity and Specificity, Turner Syndrome, Neonatal Screening, Case-Control Studies, Sequence Analysis, DNA, Polymorphism, Single Nucleotide, Chromosomes, Human, X, Microarray Analysis, Young Adult, High-Throughput Nucleotide Sequencing, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review